ArticleCancer letters2025

Corrigendum to "Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer" [Cancer Lett 448 (2019)182-196].

Kumar Nikhil et al.PubMed ↗Publisher ↗

No numbers read from the abstract.